[go: up one dir, main page]

DK453584A - Pyridinderivater til medicinsk anvendelse og farmaceutiske praeparater indeholdende pyridinderivater - Google Patents

Pyridinderivater til medicinsk anvendelse og farmaceutiske praeparater indeholdende pyridinderivater Download PDF

Info

Publication number
DK453584A
DK453584A DK453584A DK453584A DK453584A DK 453584 A DK453584 A DK 453584A DK 453584 A DK453584 A DK 453584A DK 453584 A DK453584 A DK 453584A DK 453584 A DK453584 A DK 453584A
Authority
DK
Denmark
Prior art keywords
pyridine derivatives
pharmaceutical preparations
medical use
preparations containing
containing pyridine
Prior art date
Application number
DK453584A
Other languages
English (en)
Other versions
DK453584D0 (da
DK161703C (da
DK161703B (da
Inventor
Robert Charles Hider
George Kontoghiorghes
Jack Silver
Michael Arthur Stockham
Original Assignee
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Res Dev filed Critical Nat Res Dev
Publication of DK453584D0 publication Critical patent/DK453584D0/da
Publication of DK453584A publication Critical patent/DK453584A/da
Publication of DK161703B publication Critical patent/DK161703B/da
Application granted granted Critical
Publication of DK161703C publication Critical patent/DK161703C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C07F15/025—Iron compounds without a metal-carbon linkage

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DK453584A 1983-09-23 1984-09-21 Ferrikomplekser af hydroxypyridinforbindelser, farmaceutiske praeparater indeholdende saadanne komplekser, samt anvendelsen af saadanne komplekser til fremstilling af farmaceutiske praeparater DK161703C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB838325496A GB8325496D0 (en) 1983-09-23 1983-09-23 Pharmaceutical compositions
GB8325496 1983-09-23

Publications (4)

Publication Number Publication Date
DK453584D0 DK453584D0 (da) 1984-09-21
DK453584A true DK453584A (da) 1985-03-24
DK161703B DK161703B (da) 1991-08-05
DK161703C DK161703C (da) 1992-01-20

Family

ID=10549201

Family Applications (1)

Application Number Title Priority Date Filing Date
DK453584A DK161703C (da) 1983-09-23 1984-09-21 Ferrikomplekser af hydroxypyridinforbindelser, farmaceutiske praeparater indeholdende saadanne komplekser, samt anvendelsen af saadanne komplekser til fremstilling af farmaceutiske praeparater

Country Status (11)

Country Link
US (1) US4587240A (da)
EP (1) EP0138420B1 (da)
JP (2) JPS6094966A (da)
CY (1) CY1574A (da)
DE (1) DE3480599D1 (da)
DK (1) DK161703C (da)
GB (2) GB8325496D0 (da)
GR (1) GR80444B (da)
HK (1) HK7091A (da)
SG (1) SG93290G (da)
ZA (1) ZA847409B (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308055D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB8308054D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
US4912118A (en) * 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
USRE34313E (en) * 1983-09-23 1993-07-13 National Research Development Corporation Pharmaceutical compositions
GB8325496D0 (en) * 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
GB8329043D0 (en) * 1983-10-31 1983-11-30 Hider R C Pharmaceutical compositions
US5177068A (en) * 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
US5010191A (en) * 1985-08-19 1991-04-23 The Regents Of The University Of California Imaging agents for in vivo magnetic resonance and scintigraphic imaging
CA1338702C (en) * 1987-03-05 1996-11-12 Lawrence D. Mayer High drug:lipid formulations of liposomal- antineoplastic agents
MX9203808A (es) * 1987-03-05 1992-07-01 Liposome Co Inc Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
US4908371A (en) * 1987-11-10 1990-03-13 Ciba-Geigy Corporation Esterified hydroxy dihydropyridinones for treating diseases associated with trivalent metal ion overload
GB8910521D0 (en) * 1989-05-08 1989-06-21 Nat Res Dev The stabilization of organic compounds
US5443813A (en) * 1991-06-06 1995-08-22 Associated Universities, Inc. Loading and conjugating cavity biostructures
WO1996041627A2 (en) 1995-06-10 1996-12-27 Vitra Pharmaceuticals Ltd Iron compounds, compositions, methods of making the same and uses thereof
US5667933A (en) * 1996-02-26 1997-09-16 Polaroid Corporation Image-recording element
GB9625638D0 (en) * 1996-12-10 1997-01-29 Cenes Ltd Therapeutic antioxidants for alzheimer's diease
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
WO2000041698A1 (en) 1999-01-13 2000-07-20 Bayer Corporation φ-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
WO2002024196A1 (en) * 2000-09-19 2002-03-28 Vitra Pharmaceuticals Limited Iron compositions
WO2003068228A1 (en) 2002-02-11 2003-08-21 Bayer Pharmaceuticals Corporation Aryl ureas with angiogenesis inhibiting activity
GB0211500D0 (en) * 2002-05-18 2002-06-26 Vitra Pharmaceuticals Ltd Method of forming iron hydroxypyrone compounds
US7557129B2 (en) 2003-02-28 2009-07-07 Bayer Healthcare Llc Cyanopyridine derivatives useful in the treatment of cancer and other disorders
US7595073B2 (en) * 2003-02-28 2009-09-29 Kraft Foods Global Brands Llc Use of siderophores and organic acids to retard lipid oxidation
DE602004007382T2 (de) 2003-05-20 2008-04-17 Bayer Pharmaceuticals Corp., West Haven Diaryl-harnstoffe für durch pdgfr vermittelte krankheiten
NZ544920A (en) 2003-07-23 2009-11-27 Bayer Healthcare Llc 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide and metabolites for the treatment and prevention of diseases and conditions
NZ579928A (en) 2007-03-28 2012-09-28 Apotex Technologies Inc Fluorinated derivatives of deferiprone
AU2008355464C1 (en) 2008-04-25 2014-11-20 Chiesi Farmaceutici S.P.A. Liquid formulation for deferiprone with palatable taste
KR101682966B1 (ko) 2009-07-03 2016-12-06 아포텍스 테크놀로지스 인크. 3―하이드록시피리딘―4―온의 불소화된 유도체
MX2012010950A (es) 2010-03-23 2012-11-12 Vifor Int Ag Compuestos del complejo de fe (iii) para el tratamiento y profilaxis de los sintomas de deficienza de hierro y las anemias por deficiencia de hierro.
BR112013024722B1 (pt) 2011-03-29 2022-04-12 Vifor (International) Ag Medicamento para tratamento e profilaxia de sintomas de deficiência de ferro e anemias por deficiência de ferro
EP2714030B1 (de) 2011-05-31 2015-08-12 Vifor (International) AG Fe(iii)-2,4-dioxo-1-carbonyl-komplexverbindungen zur verwendung bei der behandlung und der prophylaxe von eisenmangelerscheinungen und eisenmangelanämien
WO2013150087A1 (de) * 2012-04-05 2013-10-10 Vifor (International) Ag Fe (iii) - pyrazin - komplexverbindungen zur behandlung und prophylaxe von eisenmangelerscheinungen und eisenmangelanämien
RU2641030C2 (ru) 2012-12-21 2018-01-15 Вифор (Интернациональ) Аг Комплексные соединения трехвалентного железа для лечения и профилактики симптомов дефицита железа и железодефицитных анемий

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2748142A (en) * 1956-05-29 - process of production
GB778871A (en) * 1955-02-14 1957-07-10 Sadolin & Holmblad As Pyridinediol oxides and acetates thereof and their preparation
GB791719A (en) * 1955-02-15 1958-03-12 Sadolin & Holmblad As Improvements in or relating to the production of cyclic hydroxamic acids of the pyridine series
GB790584A (en) * 1955-02-15 1958-02-12 Sadolin & Holmblad As Improvements in or relating to the production of cyclic hydroxamic acids of the pyridine series
FR3691M (fr) * 1963-05-06 1965-11-15 Olin Mathieson Nouvelle composition pharmaceutique utile en tant que fongicide.
NL156397B (nl) * 1968-08-31 1978-04-17 Hoechst Ag Werkwijze voor het bereiden van preparaten tegen schimmelaandoeningen, gevormde preparaten, alsmede werkwijze voor het bereiden van daarvoor geschikte actieve stoffen.
US3968118A (en) * 1968-08-31 1976-07-06 Hoechst Aktiengesellschaft Process for the manufacture of 1-hydroxy-2-pyridones
US3705943A (en) * 1969-07-18 1972-12-12 Olin Corp Dialkyltin salts of substituted pyridine-1-oxides as fungicides and bactericides
EG10850A (en) * 1972-03-25 1976-06-30 Hoechst Ag Process for the preparation of 1-hydroxy-pyridones
DE2705562A1 (de) * 1977-02-10 1978-08-17 Basf Ag Verfahren zur herstellung von pyridonen
US4358455A (en) * 1980-12-23 1982-11-09 Merck & Co., Inc. Aralkylamindethanol heterocyclic compounds
JPS5832812A (ja) * 1981-08-21 1983-02-25 Lion Corp 毛髪化粧料
GB2117766B (en) * 1982-03-24 1985-08-29 Nat Res Dev Pharmaceutical compositions
GB2118176B (en) * 1982-03-24 1985-12-04 Nat Res Dev Pharmaceutical compositions
EP0105053B1 (en) * 1982-10-01 1988-01-20 Merck & Co. Inc. Aralkylaminoethanol heterocyclic compounds
GB8325496D0 (en) * 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
US4698431A (en) * 1985-11-12 1987-10-06 The United States Of America As Represented By The United States Department Of Energy Hydroxypyridonate chelating agents

Also Published As

Publication number Publication date
GR80444B (en) 1985-01-23
DK453584D0 (da) 1984-09-21
US4587240A (en) 1986-05-06
DK161703C (da) 1992-01-20
SG93290G (en) 1991-01-18
EP0138420B1 (en) 1989-11-29
EP0138420A2 (en) 1985-04-24
DE3480599D1 (de) 1990-01-04
CY1574A (en) 1991-12-20
JPH0811729B2 (ja) 1996-02-07
JPH0566385B2 (da) 1993-09-21
GB8325496D0 (en) 1983-10-26
DK161703B (da) 1991-08-05
HK7091A (en) 1991-02-01
JPS6094966A (ja) 1985-05-28
JPH05246992A (ja) 1993-09-24
EP0138420A3 (en) 1987-05-20
GB2146990A (en) 1985-05-01
GB2146990B (en) 1987-05-20
GB8423800D0 (en) 1984-10-24
ZA847409B (en) 1986-05-28

Similar Documents

Publication Publication Date Title
DK453684A (da) Pyridinderivater til medicinsk anvendelse og farmaceutiske praeparater indeholdende pyridinderivater
DK453584D0 (da) Pyridinderivater til medicinsk anvendelse og farmaceutiske praeparater indeholdende pyridinderivater
DK211084A (da) Hurtigtoploesende laegemiddelpraeparater og fremgangsmaade til fremstilling heraf
DK165112C (da) 2,2'-iminobisethanolderivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende disse
DK539789D0 (da) Carbostyrilderivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant carbostyrilderivat
DK108388A (da) Piperazinylalkylheterocycliske forbindelser og farmaceutiske praeparater indeholdende disse
DK491186D0 (da) Pyridonderivater og fremgangsmaade til fremstilling deraf
DK163923C (da) 2-phenyl-3-aminomethyl-imidazooe1,2-aaapyridinderivater og farmaceutisk praeparat indeholdende saadanne forbindelser
DK214090D0 (da) 5-aminosulfonylalkyl-indolderivater, fremgangsmaade og mellemprodukt til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
DK475684A (da) Phenothiazinderivater og farmaceutiske praeparater indeholdende phenothiazinderivaterne
DK157731C (da) Stabile pharmaceutiske praeparater indeholdende oxicamderivater og fremgangsmaade til fremstilling heraf
DK553988A (da) 4-aminopyridin-derivater og farmaceutiske praeparater indeholdende disse
DK163990C (da) Oxindol-3-carboxamid-derivater og farmaceutiske praeparater indeholdende disse
DK287188A (da) Cephalosporinforbindelser og farmaceutisk praeparat deraf
DK327983D0 (da) Farmaceutiske praeparater og produkter
DK78888D0 (da) Arylpiperazinylalkylenphenyl-heterocycliske forbindelser og farmaceutiske praeparater indeholdende disse
DK183986D0 (da) Cyklopentylaetere, fremgangsmaade til fremstilling deraf og laegemiddelpraeparat indeholdende saadanne forbindelser
DK196885D0 (da) Farmaceutiske praeparater indeholdende isoquinolinderivater og isoquinolinderivater indeholdende saadanne derivater
DK154290C (da) Vitamin-d-derivater og farmaceutiske praeparater indeholdende disse
DK269289D0 (da) Cyklopentanderivater og farmaceutiske praeparater indeholdende saadanne forbindelser
DK4487A (da) Heterocycliske forbindelser og farmaceutiske praeparater indeholdende disse
DK422984A (da) Aminocyklopentaner og farmaceutiske praeparater deraf
DK488688A (da) Azolidindion-derivater og farmaceutiske praeparater indeholdende disse
DK159779C (da) Substituerede phenoxypropylthiopyrazolo(1,5-a)-pyridin- eller -benzimidazolderivater, fremgangsmaade til fremstilling deraf og laegemiddel indeholdende disse forbindelser
DK162089C (da) 1-phenoxy-3-hydroxyindolylalkylamino-2-propanoler og farmaceutiske praeparater indeholdende disse

Legal Events

Date Code Title Description
PBP Patent lapsed